Drug Profile
Pentoxifylline - ExonHit
Alternative Names: EHT 0201; EHT 201; IkomioLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Developer ExonHit Therapeutics
- Class Anti-inflammatories; Anticoagulants; Antithrombotics; Small molecules; Vascular disorder therapies; Vasodilators; Xanthines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis; CNS disorders
Most Recent Events
- 02 Oct 2004 Discontinued - Phase-III for Amyotrophic lateral sclerosis in Belgium (unspecified route)
- 02 Oct 2004 Discontinued - Phase-III for Amyotrophic lateral sclerosis in France (unspecified route)
- 02 Oct 2004 Discontinued - Phase-III for Amyotrophic lateral sclerosis in Germany (unspecified route)